Hepatitis B transplantation: Special conditions

Seminars in Liver Disease

Volumn 20, Issue 1 SUPPL., 2000, Pages 25-28

  Tong, Myron J ^a   Terrault, Norah A ^b   Klintmalm, Goran ^c  

^a HUNTINGTON MEMORIAL HOSPITAL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Coinfection; Hepatitis C; Hepatitis D; Hepatocellular carcinoma

Indexed keywords

HEPATITIS B ANTIBODY; INTERFERON;

CONFERENCE PAPER; DISEASE ASSOCIATION; HEPATITIS B; HEPATITIS C VIRUS; HEPATITIS DELTA VIRUS; HUMAN; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; NONHUMAN; PRIORITY JOURNAL; RECURRENT DISEASE; SUPERINFECTION;

CARCINOMA, HEPATOCELLULAR; HEPATITIS B; HEPATITIS C; HEPATITIS D; HUMANS; IMMUNOTHERAPY; LIVER NEOPLASMS; LIVER TRANSPLANTATION; RECURRENCE; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 0033917859     PISSN: 02728087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (29)

1. Samuel D, Muller R, Alexander G, et al. Liver transplantation in European patients with the hepatitis B surface antigen. N Engl J Med 1993;329:1842-1847
2. Pessoa MG, Kim E, Martin P, et al. Dual effects of hepatitis B infection and hepatitis B immunoglobulin (HBIg) in reducing the incidence of acute rejection post-transplantation [abstract]. Gastroenterology 1996;114:A1322
3. Feray C, Gigon M, Samuel D, et al. Incidence of hepatitis C in patients receiving different preparations of hepatitis B immunoglobulins after liver transplantation. Ann Intern Med 1998;128:810-816
4. Liaw YF. Role of hepatitis C in dual and triple hepatitis virus infection. Hepatology 1995;22:1101-1108
5. Samuel D, Zignego A, Reynes M, et al. Long-term clinical and virological outcome after liver transplantation for cirrhosis caused by chronic delta hepatitis. Hepatology 1995;21:333-339
6. Lucey M, Graham D, Martin P, et al. Recurrence of hepatitis B and delta hepatitis after orthotopic liver transplantation. Gut 1992;33:1390-1396
7. Rizzetto M, Macagno S, Chiaberge E, et al. Liver transplantation in hepatitis delta virus disease. Lancet 1987;2:469-471
8. Ottobrelli A, Marzano A, Smedile A, et al. Patterns of hepatitis delta virus reinfection and disease in liver transplantation. Gastroenterology 1991;101:1649-1655
9. Smedile A, Casey JL, Cote PJ, et al. Hepatitis D viremia following orthotopic liver transplantation involves a typical HDV virion with a hepatitis B surface antigen envelope. Hepatology 1998;27:1723-1729
10. Hopf U, Neuhaus P, Lobeck H, et al. Follow-up of recurrent hepatitis B and delta infection in liver allograft recipients after treatment with recombinant interferon-α. J Hepatol 1991;13: 339-346
11. Wright TL, Donegan E, Hsu HH, et al. Recurrent and acquired hepatitis C viral injection in liver transplant recipients. Gantroenterology 1992;103:317-322
12. Gayowski T, Marino IR, Singh N, et al. Orthotopic liver transplantation in high-risk patients: Risk factors associated with mortality and infectious morbidity. Transplantation 1998;65: 499-504
13. Huang E, Wright T, Lake J, Combs C, Ferrell L. Hepatitis B and C coinfections and persistent hepatitis B infections: Clinical outcome and liver pathology after transplantation. Hepatology 1996;23:396-404
14. Hwang SJ, Tong MJ, Lai PP, et al. Evaluation of hepatitis B and C viral markers: Clinical significance in Asian and Caucasian patients with hepatocellular carcinoma in the United States of America. J Gastroenterol Hepatol 1996;11:949-954
15. Collier J, Sherman M. Screening for hepatocellular carcinoma. Hepatology 1998;27:273-278
16. Chen CJ, Yu MW, Liaw YF. Epidemiological characteristics and risk factors of hepatocellular carcinoma. J Gastroenterol Hepatol 1997;12:S294-S308
17. Benvegnu L, Fattovich G, Noventa F, et al. Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma in cirrhosis. A prospective study. Cancer 1994;74:2442-2448
18. Yu MC, Yuan JM, Ross RK, Govindarajan S. Presence of antibodies to the hepatitis B surface antigen is associated with an excess risk for hepatocellular carcinoma among non-Asians in Los Angeles County, California. Hepatology 1997;25:226-228
19. Chen DS, Hsu NH, Sung JL, et al. A mass vaccinatin program in Taiwan against hepatitis B virus infection in infants of hepatitis B surface antigen-carrier mothers. JAMA 1987;257:2597-2603
20. Tabor E. Hepatocellular carcinoma: Possible etiologies in patients without serologic evidence of hepatitis B virus infection. J Med Virol 1989;27:1-6
21. Petry W, Heintges T, Hensel F, et al. Hepatocellular carcinoma in Germany. Epidemiology, etiology, clinical aspects and prognosis in 100 consecutive patients of a university clinic. Z Gastroenterol 1997;35:1059-1067
22. Desmet VJ, Gerber MA, Hoofnagle JH, et al. Classification of chronic hepatitis: Diagnosis, grading and staging. Hepatology 1994;19:1513-1520
23. Bruix J, Llovet JM, Castells A, et al. Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: Results of a randomized, controlled trial in a single institution. Hepatology 1998;27:1578-1583
24. Stuart KR, Anand AJ, Jenkins RL. Hepatocellular carcinoma in the United States. Prognostic features, treatment outcome, and survival. Cancer 1996;77:2217-2222
25. Simonetti RG, Liberati A, Angiolini C, Pagliaro L. Treatment of hepatocellular carcinoma: A systemic review of randomized controlled trials. Ann Oncol 1997;8:117-136
26. Chen RC, Wang CK, Chiang LC, et al. Intra-arterial carbon dioxide-enhanced ultrasonogram of hepatocellular carcinoma treated by transcatheter arterial embolization and percutaneous ethanol injection. J Gastroenterol Hepatol 1998;13:41-46
27. Mazziotti A, Grazi GL, Cavallari A. Surgical treatment of hepatocellular carcinoma on cirrhosis: A Western experience. Hepatogastroenterology 1998;45(Suppl 3):1281-1287
28. Venook AP, Ferrell LD, Roberts JP, et al. Liver transplantation for hepatocellular carcinoma: Results with preoperative chemoembolization. Liver Transplant Surg 1995;1:242-248
29. Figueras J, Jaurrieta E, Valls C, et al. Survival after liver transplantation in cirrhotic patients with and without hepatocellular carcinoma: A comparative study. Hepatology 1997;25:1485-1489